Abstract
The Ras/Raf/MEK/ERK signal transduction is a key oncogenic pathway implicated in a variety of human cancers. We have identified a novel series of pyrazolylpyrroles as inhibitors of ERK. Aided by the discovery of two distinct binding modes for the pyrazolylpyrrole scaffold, structure-guided optimization culminated in the discovery of 6p, a potent and selective inhibitor of ERK.
Original language | English |
---|---|
Pages (from-to) | 1280-1287 |
Number of pages | 8 |
Journal | Journal of Medicinal Chemistry |
Volume | 50 |
Issue number | 6 |
DOIs | |
State | Published - Mar 22 2007 |